These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31498131)

  • 61. Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study.
    Nakahara K; Nakane S; Ishii K; Ikeda T; Ando Y
    Sci Rep; 2023 Feb; 13(1):2210. PubMed ID: 36750613
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison study of differential abundance testing methods using two large Parkinson disease gut microbiome datasets derived from 16S amplicon sequencing.
    Wallen ZD
    BMC Bioinformatics; 2021 May; 22(1):265. PubMed ID: 34034646
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
    Killinger B; Labrie V
    J Parkinsons Dis; 2019; 9(s2):S345-S358. PubMed ID: 31609697
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota.
    Yemula N; Dietrich C; Dostal V; Hornberger M
    J Parkinsons Dis; 2021; 11(4):1491-1505. PubMed ID: 34250955
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Gut Mycobiome in Parkinson's Disease.
    Cirstea MS; Sundvick K; Golz E; Yu AC; Boutin RCT; Kliger D; Finlay BB; Appel-Cresswell S
    J Parkinsons Dis; 2021; 11(1):153-158. PubMed ID: 33164944
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

  • 68. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
    Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H
    Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.
    Romano S; Savva GM; Bedarf JR; Charles IG; Hildebrand F; Narbad A
    NPJ Parkinsons Dis; 2021 Mar; 7(1):27. PubMed ID: 33692356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.
    Yang X; Qian Y; Xu S; Song Y; Xiao Q
    Front Aging Neurosci; 2017; 9():441. PubMed ID: 29358918
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson's disease.
    Wang S; Li N; Zou H; Wu M
    Neurosci Lett; 2019 Mar; 696():93-98. PubMed ID: 30572101
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease.
    Ilieva NM; Wallen ZD; De Miranda BR
    Toxicol Appl Pharmacol; 2022 Sep; 451():116176. PubMed ID: 35914559
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differences in the gut microbiome across typical ageing and in Parkinson's disease.
    Nuzum ND; Szymlek-Gay EA; Loke S; Dawson SL; Teo WP; Hendy AM; Loughman A; Macpherson H
    Neuropharmacology; 2023 Sep; 235():109566. PubMed ID: 37150399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.
    Vascellari S; Melis M; Palmas V; Pisanu S; Serra A; Perra D; Santoru ML; Oppo V; Cusano R; Uva P; Atzori L; Morelli M; Cossu G; Manzin A
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33499229
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
    Chiang HL; Lin CH
    J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.
    Cassani E; Barichella M; Cancello R; Cavanna F; Iorio L; Cereda E; Bolliri C; Zampella Maria P; Bianchi F; Cestaro B; Pezzoli G
    Parkinsonism Relat Disord; 2015 Apr; 21(4):389-93. PubMed ID: 25707302
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
    Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
    Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.
    Dutta SK; Verma S; Jain V; Surapaneni BK; Vinayek R; Phillips L; Nair PP
    J Neurogastroenterol Motil; 2019 Jul; 25(3):363-376. PubMed ID: 31327219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.